Literature DB >> 32732268

Pressing Issues in COVID-19: Probable Cause to Seize SARS-CoV-2 for Its Preferential Involvement of Posterior Circulation Manifesting as Severe Posterior Reversible Encephalopathy Syndrome and Posterior Strokes.

F D'Amore1, G Vinacci2, E Agosti3, L P Cariddi4,5, A V Terrana1, F A Vizzari1, M Mauri4, A Giorgianni1.   

Abstract

Since December 2019, a novel Severe Acute Respiratory Syndrome coronavirus 2 from China has rapidly spread worldwide. Although respiratory involvement is the mainstay of coronavirus disease 2019 (COVID-19), systemic involvement has recently drawn more attention. In particular, a number of recent articles have shed light on the nervous system as one of the possible targets. At our institution, we observed 15 patients with acute brain vascular manifestations; most interesting, we had a higher prevalence of the posterior circulation acute impairment. In our series, 7 patients had acute posterior cerebral injury: 1, hemorrhagic posterior reversible encephalopathy syndrome; 5, posterior circulation ischemic stroke; and 1, parieto-occipital hemorrhagic stroke. On the basis of our evidence and previous basic science reports, we believe a common etiopathogenetic thread may connect ischemic/hemorrhagic events of the posterior circulation and posterior reversible encephalopathy syndrome in the setting of COVID-19.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2020        PMID: 32732268      PMCID: PMC7661064          DOI: 10.3174/ajnr.A6679

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

Review 1.  Endothelial dysfunction: a marker of atherosclerotic risk.

Authors:  Piero O Bonetti; Lilach O Lerman; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

Review 2.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

3.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

Review 4.  Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.

Authors:  Zhengqian Li; Taotao Liu; Ning Yang; Dengyang Han; Xinning Mi; Yue Li; Kaixi Liu; Alain Vuylsteke; Hongbing Xiang; Xiangyang Guo
Journal:  Front Med       Date:  2020-05-04       Impact factor: 4.592

5.  COVID-19 and intracerebral haemorrhage: causative or coincidental?

Authors:  A Sharifi-Razavi; N Karimi; N Rouhani
Journal:  New Microbes New Infect       Date:  2020-03-27

Review 6.  Neurological manifestations and complications of COVID-19: A literature review.

Authors:  Imran Ahmad; Farooq Azam Rathore
Journal:  J Clin Neurosci       Date:  2020-05-06       Impact factor: 1.961

7.  Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.

Authors:  Thomas J Oxley; J Mocco; Shahram Majidi; Christopher P Kellner; Hazem Shoirah; I Paul Singh; Reade A De Leacy; Tomoyoshi Shigematsu; Travis R Ladner; Kurt A Yaeger; Maryna Skliut; Jesse Weinberger; Neha S Dangayach; Joshua B Bederson; Stanley Tuhrim; Johanna T Fifi
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

8.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

Review 9.  Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome.

Authors:  Archana Hinduja
Journal:  Front Neurol       Date:  2020-02-14       Impact factor: 4.003

10.  Neurologic Features in Severe SARS-CoV-2 Infection.

Authors:  Julie Helms; Stéphane Kremer; Hamid Merdji; Raphaël Clere-Jehl; Malika Schenck; Christine Kummerlen; Olivier Collange; Clotilde Boulay; Samira Fafi-Kremer; Mickaël Ohana; Mathieu Anheim; Ferhat Meziani
Journal:  N Engl J Med       Date:  2020-04-15       Impact factor: 91.245

View more
  5 in total

Review 1.  COVID-19 and cerebrovascular diseases: a comprehensive overview.

Authors:  Georgios Tsivgoulis; Lina Palaiodimou; Ramin Zand; Vasileios Arsenios Lioutas; Christos Krogias; Aristeidis H Katsanos; Ashkan Shoamanesh; Vijay K Sharma; Shima Shahjouei; Claudio Baracchini; Charalambos Vlachopoulos; Rossetos Gournellis; Petros P Sfikakis; Else Charlotte Sandset; Andrei V Alexandrov; Sotirios Tsiodras
Journal:  Ther Adv Neurol Disord       Date:  2020-12-08       Impact factor: 6.570

2.  Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy.

Authors:  Umberto Pensato; Lorenzo Muccioli; Ilaria Cani; Damir Janigro; Pier Luigi Zinzani; Maria Guarino; Pietro Cortelli; Francesca Bisulli
Journal:  Ann Clin Transl Neurol       Date:  2021-03-29       Impact factor: 4.511

3.  Posterior reversible encephalopathy syndrome - A pathology that should not be overlooked in the era of COVID-19.

Authors:  Patricia Ioan; Athena Cristina Ribigan; Octaviana Rusu; Ionut Flavius Bratu; Raluca Stefania Badea; Florina Antochi
Journal:  Am J Emerg Med       Date:  2022-03-13       Impact factor: 4.093

4.  Special report of the RSNA COVID-19 task force: systematic review of outcomes associated with COVID-19 neuroimaging findings in hospitalized patients.

Authors:  Monique A Mogensen; Pattana Wangaryattawanich; Jason Hartman; Christopher G Filippi; Daniel S Hippe; Nathan M Cross
Journal:  Br J Radiol       Date:  2021-04-29       Impact factor: 3.039

Review 5.  A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).

Authors:  Bahar Bahranifard; Somayeh Mehdizadeh; Ali Hamidi; Alireza Khosravi; Ramin Emami; Kamran Mirzaei; Reza Nemati; Fatemeh Nemati; Majid Assadi; Ali Gholamrezanezhad
Journal:  Neuroradiol J       Date:  2021-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.